Elliot Maltz
Direttore Finanziario/CFO presso ALIMERA SCIENCES, INC.
Patrimonio netto: 271 $ in data 31/12/2023
Posizioni attive di Elliot Maltz
Società | Posizione | Inizio | Fine |
---|---|---|---|
ALIMERA SCIENCES, INC. | Direttore Finanziario/CFO | 02/01/2024 | - |
Treasurer | 02/01/2024 | - |
Storia della carriera di Elliot Maltz
Precedenti posizioni note di Elliot Maltz
Società | Posizione | Inizio | Fine |
---|---|---|---|
ORGENESIS INC. | Direttore Finanziario/CFO | 01/09/2023 | 31/12/2023 |
Segretario Aziendale | 01/09/2023 | 31/12/2023 | |
Treasurer | 01/09/2023 | 31/12/2023 | |
GELESIS HOLDINGS, INC. | Comptroller/Controller/Auditor | 13/01/2022 | 15/08/2023 |
Responsabile della Conformità | 01/10/2022 | 15/08/2023 | |
Direttore Finanziario/CFO | 13/01/2022 | 15/08/2023 | |
Segretario Aziendale | 01/10/2022 | 15/08/2023 | |
Treasurer | 13/01/2022 | 15/08/2023 | |
GELESIS INC | Direttore Finanziario/CFO | 01/05/2021 | 01/01/2022 |
Treasurer | 01/05/2015 | 01/01/2022 | |
SAPIENT CORPORATION | Comptroller/Controller/Auditor | 01/04/2013 | 01/03/2014 |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | 01/01/2007 | 01/04/2013 |
Formazione di Elliot Maltz
Elon University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Posizioni
Director of Finance/CFO | 4 |
Treasurer | 4 |
Comptroller/Controller/Auditor | 3 |
Settori
Health Technology | 5 |
Commercial Services | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
GELESIS HOLDINGS, INC. | Health Technology |
ORGENESIS INC. | Health Technology |
ALIMERA SCIENCES, INC. | Health Technology |
Aziende private | 3 |
---|---|
Gelesis, Inc.
Gelesis, Inc. BiotechnologyHealth Technology Gelesis, Inc. operates as a consumer-centered biotherapeutics company, which engages in the development of novel therapies to induce weight loss and metabolic disorders. Its commercial product portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease /Non-alcoholic Steatohepatitis, and Functional Constipation. The company was founded by Yishai Zohar in 2006 and is headquartered in Boston, MA. | Health Technology |
Sapient Corp.
Sapient Corp. Miscellaneous Commercial ServicesCommercial Services Sapient Corp. provides consultancy and interactive marketing services. The company was founded by James Stuart Moore and Jerry A. Greenberg in 1990 and is headquartered in Boston, MA. | Commercial Services |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
- Borsa valori
- Insiders
- Elliot Maltz
- Esperienza